Explore how probiotics are emerging as a promising additional treatment for rheumatoid arthritis through the gut-joint axis and cutting-edge research.
Explore how gut microbiome influences methotrexate response in rheumatoid arthritis treatment through pharmacomicrobiology research.
Discover how Porphyromonas gingivalis and its enzyme PPAD may trigger rheumatoid arthritis through molecular mimicry and citrullination.
Explore the fascinating link between oral microbiome disruptions and rheumatoid arthritis development through molecular mimicry, bacterial translocation, and inflammation mechanisms.
Exploring how gut microbiome disturbances contribute to rheumatic diseases like rheumatoid arthritis, lupus, and ankylosing spondylitis through immune dysregulation and inflammation.